Endothelial colony-forming cells from preterm infants are increased and more susceptible to hyperoxia

Christopher D Baker1, Sharon L Ryan, David A Ingram

  • 1Pediatric Heart Lung Center, University of Colorado, Denver School of Medicine, Aurora, CO 80045, USA. christopher.baker@uchsc.edu

Insights

Preterm infants have more endothelial progenitor cells (ECFCs) that grow faster, but they are vulnerable to hyperoxia. Antioxidants can protect these vital cells in premature babies.

Area of Science:

  • Neonatal research
  • Vascular biology
  • Stem cell science

Background:

  • Bronchopulmonary dysplasia (BPD) is a chronic lung disease linked to preterm birth and hyperoxia.
  • Endothelial colony-forming cells (ECFCs) are crucial for vascular repair.
  • The impact of hyperoxia on ECFCs, particularly from preterm infants, is not well understood.

Purpose of the Study:

  • To investigate if umbilical cord blood from premature infants contains more ECFCs with higher growth potential.
  • To determine the susceptibility of preterm ECFCs to hyperoxia.

Main Methods:

  • Quantified ECFC colonies from preterm and term umbilical cord blood.
  • Assessed ECFC growth kinetics in room air and hyperoxia (40% oxygen).
  • Characterized ECFCs using immunohistochemistry and flow cytometry.

Main Results:

  • Preterm cord blood yielded significantly more ECFCs than term cord blood.
  • Preterm ECFCs exhibited increased growth compared to term ECFCs.
  • Hyperoxia impaired preterm ECFC growth, but not term ECFCs; antioxidants mitigated this effect.

Conclusions:

  • Preterm infants have more numerous and faster-proliferating ECFCs.
  • Preterm ECFCs are more susceptible to hyperoxic injury.
  • Antioxidant treatment protects preterm ECFCs from hyperoxia, suggesting a therapeutic avenue.
Abstract